YAP1 and cancer: Overall, these data supported a model where HSF1 in CAFs leads to DKK3 upregulation, which in turn potentiates YAP/TAZ activity leading to increased ECM remodelling and promotion of cancer cell growth and invasion (Fig. 6h).